https://feeds.newsfilecorp.com/company/7197 Latest news from Appili Therapeutics Inc., as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Fri, 14 Aug 2026 17:42:36 -0400 https://images.newsfilecorp.com/logos/7197.jpg https://feeds.newsfilecorp.com/company/7197 https://www.newsfilecorp.com/release/309716/Appili-Therapeutics-Reports-Financial-and-Operational-Results-for-First-Quarter-of-Fiscal-Year-2027 Appili adopts a new business strategy that focuses on the biodefence sector Halifax, Nova Scotia--(Newsfile Corp. - August 14, 2026) - Appili Therapeutics Inc. (TSX: APLI) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the first quarter of its fiscal year 2027, which ended on June 30, 2026. All figures are in Canadian dollars...<img src="https://api.newsfilecorp.com/newsinfo/309716/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Fri, 14 Aug 2026 17:00:00 -0400 en https://www.newsfilecorp.com/release/309716 Appili adopts a new business strategy that focuses on the biodefence sector